Preventing cancer therapy-related heart failure: the need for novel studies
Conclusion
Only concomitant statin and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapies were associated with significantly lower risk of anticancer therapy-related heart failure.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Cardiotoxicity Source Type: research
More News: Beta-Blockers | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Cardiology | Cardiomyopathy | Cardiovascular | Chemotherapy | Cholesterol | Colorectal Cancer | Databases & Libraries | Dilated Cardiomyopathy | Heart | Heart Failure | Hungary Health | Statin Therapy | Study | Xeloda